Publications

Publication List

1. Cecily Hunter and Anthony D LaMontagne, "Investigating 'Community' through a History of Responses to Asbestos-Related Disease in an Australian Industrial Region", Social History of Medicine, Advance Access published June 17, 2008.
2. Creaney J, Yeoman D, Demelker Y, Segal A, Musk AW, Skates SJ, Robinson BW. 2008. Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma. Journal of Thoracic Oncology 3(8):851-7. [NCBI PubMed Entry]
3. Park EK, Sandrini A, Yates DH, Thomas PS, Creaney J, Robinson BW, Johnson AR. 2008. Soluble Mesothelin Related Protein (SMRP) in an Asbestos Exposed Population. American Journal of Respiratory and Critical Care Medicine [in press]. [NCBI PubMed Entry]
4. Creaney J, Segal A, Sterrett G, Platten MA, Baker E, Murch AR, Nowak AK, Robinson BW, Millward MJ. 2008. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma. British Journal of Cancer 98(9):1562-9. [NCBI PubMed Entry]
5. Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW. 2007. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Chest 132(4):1239-46. [NCBI PubMed Entry]
6. Creaney J, Yeoman D, Naumoff LK, Hof M, Segal A, Musk AW, De Klerk N, Horick N, Skates SJ, Robinson BW. 2007. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 62(7):569-76. [NCBI PubMed Entry]
7. Sherwood AL, Mutsaers SE, Peeva VK, Robinson C, Desilva CJ, Swanson NR, Lake RA. 2008. Spontaneously immortalized mouse mesothelial cells display characteristics of malignant transformation. Cell Proliferation 41(6):894-908. [NCBI PubMed Entry]
8. van der Most RG, Currie AJ, Mahendran S, Prosser A, Darabi A, Robinson BW, Nowak AK, Lake RA. 2008. Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. Cancer Immunology, Immunotherapy [Epub ahead of print]. [NCBI PubMed Entry]

Media Articles and Quotes

1. Carmel Egan, "Why the Valley needs to hear 'sorry'", The Sunday Age, 8th June 2008.
   (Quotes Tony LaMontagne)
2. Leah Mether, "Asbestos study may aid detection", The Latrobe Valley Express, 5th March 2007.
   (Quotes Andrew Holloway)
3. Anthony LaMontagne, "Register 'more important' now", Occupational Health News, Issue 733, May 9, 2007. [PDF 0.1MB]